Possible influence of stroke etiology on hemorrhagic transformation following thrombolysis in warfarin-treated patients

Archives of Neurology

Volumn 67, Issue 11, 2010, Pages 1413-

  Dowlatshahi, Dar ^a   O'Donnell, Martin ^b   Sharma, Mukul ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; NOTE; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; HEMORRHAGE; HUMANS; STROKE; THROMBOLYTIC THERAPY; WARFARIN;

EID: 78149472566     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.286     Document Type: Note

References (5)

1. Prabhakaran S, Rivolta J, Vieira JR, et al. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2010;67(5):559-563.
2. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
3. Alexandrov AV, Black SE, Ehrlich LE, Caldwell CB, Norris JW. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke. Stroke. 1997;28(6):1198-1202.
4. Hallevi H, Albright KC, Martin-Schild S, Barreto AD, Grotta JC, Savitz SI. The complications of cardioembolic stroke: lessons from the VISTA database. Cerebrovasc Dis. 2008;26(1):38-40.
5. O'Donnell M, Oczkowski W, Fang J, et al; Investigators of the Registry of the Canadian Stroke Network. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol. 2006;5(9):749-754.